Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evan Mayo-Wilson

Showing results (51-60 of 129) with videos related to

Pageof 13
Sort By:
The British Journal of Psychiatry : the Journal of Mental Science|September 14, 2013
Developing a reporting guideline for social and psychological intervention trialsEvan Mayo-Wilson, Paul Montgomery, Sally Hopewell, et al.
JAMA Network Open|January 8, 2024
Publication of Results of Registered Trials With Published Study Protocols, 2011-2022Colby J Vorland, Andrew W Brown, Halil Kilicoglu, et al.
Journal of Clinical Epidemiology|November 7, 2021
Harms in Systematic Reviews Paper 3: Given the same data sources, systematic reviews of gabapentin have different results for harmsRiaz Qureshi, Evan Mayo-Wilson, Thanitsara Rittiphairoj, et al.
Journal of Clinical Epidemiology|May 6, 2019
Harms are assessed inconsistently and reported inadequately Part 2: nonsystematic adverse eventsEvan Mayo-Wilson, Nicole Fusco, Tianjing Li, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|October 16, 2020
Creating a Program to Support Registering and Reporting Clinical Trials at Johns Hopkins UniversityAnthony Keyes, Evan Mayo-Wilson, Prince Nuamah, et al.
Journal of Clinical Epidemiology|May 23, 2017
Multiple outcomes and analyses in clinical trials create challenges for interpretation and research synthesisEvan Mayo-Wilson, Nicole Fusco, Tianjing Li, et al.
Trials|September 7, 2019
Opportunities for selective reporting of harms in randomized clinical trials: Selection criteria for non-systematic adverse eventsEvan Mayo-Wilson, Nicole Fusco, Hwanhee Hong, et al.
BMJ (Clinical Research Ed.)|May 24, 2013
Recognition, assessment and treatment of social anxiety disorder: summary of NICE guidanceStephen Pilling, Evan Mayo-Wilson, Ifigeneia Mavranezouli, et al.
Journal of Clinical Epidemiology|November 7, 2021
Harms in Systematic Reviews Paper 2: Methods used to assess harms are neglected in systematic reviews of gabapentinRiaz Qureshi, Evan Mayo-Wilson, Thanitsara Rittiphairoj, et al.
Journal of Clinical Epidemiology|May 6, 2019
Harms are assessed inconsistently and reported inadequately part 1: systematic adverse eventsEvan Mayo-Wilson, Nicole Fusco, Tianjing Li, et al.
Pageof 13

Showing results (51-60 of 129) with videos related to

Sort By:
Pageof 13
The British Journal of Psychiatry : the Journal of Mental Science|September 14, 2013
Developing a reporting guideline for social and psychological intervention trialsEvan Mayo-Wilson, Paul Montgomery, Sally Hopewell, et al.
JAMA Network Open|January 8, 2024
Publication of Results of Registered Trials With Published Study Protocols, 2011-2022Colby J Vorland, Andrew W Brown, Halil Kilicoglu, et al.
Journal of Clinical Epidemiology|November 7, 2021
Harms in Systematic Reviews Paper 3: Given the same data sources, systematic reviews of gabapentin have different results for harmsRiaz Qureshi, Evan Mayo-Wilson, Thanitsara Rittiphairoj, et al.
Journal of Clinical Epidemiology|May 6, 2019
Harms are assessed inconsistently and reported inadequately Part 2: nonsystematic adverse eventsEvan Mayo-Wilson, Nicole Fusco, Tianjing Li, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|October 16, 2020
Creating a Program to Support Registering and Reporting Clinical Trials at Johns Hopkins UniversityAnthony Keyes, Evan Mayo-Wilson, Prince Nuamah, et al.
Journal of Clinical Epidemiology|May 23, 2017
Multiple outcomes and analyses in clinical trials create challenges for interpretation and research synthesisEvan Mayo-Wilson, Nicole Fusco, Tianjing Li, et al.
Trials|September 7, 2019
Opportunities for selective reporting of harms in randomized clinical trials: Selection criteria for non-systematic adverse eventsEvan Mayo-Wilson, Nicole Fusco, Hwanhee Hong, et al.
BMJ (Clinical Research Ed.)|May 24, 2013
Recognition, assessment and treatment of social anxiety disorder: summary of NICE guidanceStephen Pilling, Evan Mayo-Wilson, Ifigeneia Mavranezouli, et al.
Journal of Clinical Epidemiology|November 7, 2021
Harms in Systematic Reviews Paper 2: Methods used to assess harms are neglected in systematic reviews of gabapentinRiaz Qureshi, Evan Mayo-Wilson, Thanitsara Rittiphairoj, et al.
Journal of Clinical Epidemiology|May 6, 2019
Harms are assessed inconsistently and reported inadequately part 1: systematic adverse eventsEvan Mayo-Wilson, Nicole Fusco, Tianjing Li, et al.
Pageof 13